Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
Genvoya (Cobicistat,Elvitegravir,Emtricitabine,Tenofovir)
General Medication Fact Sheet for Genvoya
| Field | Information |
|---|---|
| Medication Name | Genvoya |
| Generic Name | Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide |
| Boxed/Label Warning | Post treatment acute exacerbation of hepatitis B |
| Purpose | Complete HIV-1 treatment regimen in adults and pediatric patients |
| Mechanism of Action | Inhibits HIV-1 replication by blocking integrase, boosting elvitegravir levels, and inhibiting reverse transcriptase |
| Dosage Forms | Oral tablets |
| Available Strengths | 150 mg elvitegravir / 150 mg cobicistat / 200 mg emtricitabine / 10 mg tenofovir alafenamide |
| Dosage Frequency | Once daily |
| Common Side Effects | Nausea, diarrhea, fatigue, headache |
| Serious Side Effects | New or worsening kidney problems, bone problems, changes in body fat, immune reconstitution syndrome, lactic acidosis, severe liver problems |
| Drug Interactions | Many potential interactions. Consult healthcare provider or pharmacist, including CYP3A inducers, P-gp inducers, and certain antacids. |
| Important Notes | Take with food. Do not take with certain medications. Regular monitoring of kidney function is important. |
| Storage | Store at room temperature away from moisture and light |
| Missed Dose | Take as soon as you remember unless it is almost time for your next dose. Do not double the dose. |
| Alternatives | Triumeq (dolutegravir/abacavir/lamivudine), Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide), Dovato (dolutegravir/lamivudine) |
Genvoya Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Triumeq (dolutegravir/abacavir/lamivudine) | Integrase inhibitor/NRTI combination | Complete single-tablet regimen. Requires HLA-B*5701 testing. |
| Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) | Integrase inhibitor/NRTI combination | Another complete single-tablet regimen. |
| Dovato (dolutegravir/lamivudine) | Integrase inhibitor/NRTI combination | Two-drug complete regimen, may not be suitable for all patients. |
Genvoya Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Nausea | New or worsening kidney problems |
| Diarrhea | Bone problems (bone pain, softening) |
| Fatigue | Changes in body fat (increased fat in upper back and stomach area, decreased fat in legs and arms) |
| Headache | Immune Reconstitution Syndrome |
| Dizziness | Lactic acidosis (stomach upset, dizziness, feeling cold, fast or uneven heart rate) |
Genvoya Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| HIV-1 Infection (Adults and Pediatric Patients >= 25 kg) | One tablet daily | One tablet daily | Take orally with food. Do not use with certain other medications. |
Genvoya Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $30 |
| Without Insurance (U.S.) | $4500 |
| From Canada | $3800 |
